Literature DB >> 21432365

Effect of β(3)-adrenergic receptor gene polymorphism on body weight change in middle-aged, overweight women.

Jung Su Lee1, Kiyoshi Kawakubo, Shuji Inoue, Akira Akabayashi.   

Abstract

OBJECTIVES: To examine the effects of β(3)-adrenergic receptor gene polymorphism on body weight change during a weight reduction program for middle-aged, overweight women with careful consideration of their energy intake and expenditure.
DESIGN: Intervention study of weight reduction for 12 weeks in a community setting.
SUBJECTS: Eighty overweight middle-aged women who completed the individualized lifestyle modification program. MEASUREMENTS: β(3)-adrenergic receptor gene polymorphism was identified by polymerase chain reaction and consecutive restriction fragment-length polymorphism analysis. Anthropometrical parameters, lifestyle factors, blood lipid and glucose levels, physical activity level and energy intake were measured before and at the end of the program.
RESULTS: The numbers of subjects with the Trp64Trp, Trp64Arg, and Arg64Arg genotypes were 45, 30 and 5, respectively. Baseline characteristics among subjects with the 64Arg allele had significantly smaller decrease in body weight and energy intake than those without the 64Arg allele. The change of other clinical characteristics did not differ between the two groups. After adjusting for the %change of energy intake, the %change of body weight did not differ between the two groups.
CONCLUSION: The 64Arg allele of the β(3)-AR gene is not likely to be the factor determining the difficulty in losing body weight in Japanese middle-aged, overweight women. Lifestyle factors, such as the decrease in energy intake, might mask the effect of the 64Arg allele on body weight loss. Specific considerations for the management of energy intake would be needed to promote body weight loss for those with the 64Arg allele.

Entities:  

Keywords:  body weight change; energy intake; physical activity; polymorphism; β3-adrenergic receptor gene

Year:  2006        PMID: 21432365      PMCID: PMC2723635          DOI: 10.1007/BF02898145

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  35 in total

Review 1.  [Beta 3-adrenergic receptor gene variant].

Authors:  J S Lee
Journal:  Nihon Rinsho       Date:  2001-03

2.  Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant.

Authors:  A Tchernof; R D Starling; A Turner; A R Shuldiner; J D Walston; K Silver; E T Poehlman
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

3.  A study on the genetics of obesity: influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors.

Authors:  H Benecke; H Topak; A von zur Mühlen; F Schuppert
Journal:  Exp Clin Endocrinol Diabetes       Date:  2000       Impact factor: 2.949

4.  No effect of the Trp64Arg beta(3)-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, caucasian postmenopausal women.

Authors:  Eric S Rawson; Amy Nolan; Kristi Silver; Alan R Shuldiner; Eric T Poehlman
Journal:  Metabolism       Date:  2002-06       Impact factor: 8.694

5.  Arg64 beta3-adrenoceptor variant and the components of energy expenditure.

Authors:  Jeremy Walston; Ross E Andersen; Michael Seibert; Heather Hilfiker; Brock Beamer; Jacob Blumenthal; Eric T Poehlman
Journal:  Obes Res       Date:  2003-04

6.  Effects of uncoupling protein 1 and beta3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women.

Authors:  Hiroshi Matsushita; Takumi Kurabayashi; Masatoshi Tomita; Nozomi Kato; Kenichi Tanaka
Journal:  Maturitas       Date:  2003-05-30       Impact factor: 4.342

7.  Tissue distribution of beta 3-adrenergic receptor mRNA in man.

Authors:  S Krief; F Lönnqvist; S Raimbault; B Baude; A Van Spronsen; P Arner; A D Strosberg; D Ricquier; L J Emorine
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

Review 8.  The human beta 3-adrenergic receptor: relationship with atypical receptors.

Authors:  L J Emorine; B Fève; J Pairault; M M Briend-Sutren; C Nahmias; S Marullo; C Delavier-Klutchko; D A Strosberg
Journal:  Am J Clin Nutr       Date:  1992-01       Impact factor: 7.045

9.  Additive effect of the mutations in the beta3-adrenoceptor gene and UCP3 gene promoter on body fat distribution and glycemic control after weight reduction in overweight subjects with CAD or metabolic syndrome.

Authors:  O Y Kim; E Y Cho; H Y Park; Y Jang; J H Lee
Journal:  Int J Obes Relat Metab Disord       Date:  2004-03

10.  Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.

Authors:  K Clément; C Vaisse; B S Manning; A Basdevant; B Guy-Grand; J Ruiz; K D Silver; A R Shuldiner; P Froguel; A D Strosberg
Journal:  N Engl J Med       Date:  1995-08-10       Impact factor: 91.245

View more
  3 in total

1.  Effect of the β3-adrenergic receptor gene polymorphism Trp64Arg on BMI reduction associated with an exercise-based intervention program in Japanese middle-aged males.

Authors:  Aya Tahara; Yoneatsu Osaki; Takuji Kishimoto
Journal:  Environ Health Prev Med       Date:  2010-05-26       Impact factor: 3.674

Review 2.  The role of genes involved in lipolysis on weight loss program in overweight and obese individuals.

Authors:  Harry Freitag Luglio; Dian Caturini Sulistyoningrum; Rina Susilowati
Journal:  J Clin Biochem Nutr       Date:  2015-08-19       Impact factor: 3.114

Review 3.  Genetic Variation of Fatty Acid Oxidation and Obesity, A Literature Review.

Authors:  Harry Freitag Luglio
Journal:  Int J Biomed Sci       Date:  2016-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.